You now have the opportunity to read the first multicenter clinical study carried out in several Latin American countries that clearly demonstrates that chlorine dioxide is a fully effective treatment against COVID-19.
The highly satisfactory results of the first multicenter clinical study in humans, on the effectiveness of chlorine dioxide (ClO2) as CDS in the treatment of COVID-19, were successfully published in the scientific journal Journal of Molecular and Genetic Medicine (ISSN: 1747-0862).
The study was registered and accepted in clinicaltrials.gov on April 7, 2020 (NCT 04343742) and falls within the studies categorized as ECE (quasi-experimental studies) by the NCBI (National Center for Biotechnology Information).